351 related articles for article (PubMed ID: 28345127)
1. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.
Cui P; Liu H; Sun J; Amizuka N; Sun Q; Li M
Histol Histopathol; 2018 Jan; 33(1):89-99. PubMed ID: 28345127
[TBL] [Abstract][Full Text] [Related]
2. Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model.
Komatsu K; Shimada A; Shibata T; Wada S; Ideno H; Nakashima K; Amizuka N; Noda M; Nifuji A
J Endocrinol; 2013 Nov; 219(2):145-58. PubMed ID: 24096963
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
[TBL] [Abstract][Full Text] [Related]
4. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
Amanat N; McDonald M; Godfrey C; Bilston L; Little D
J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160
[TBL] [Abstract][Full Text] [Related]
5. Effects of Potentilla fulgens as a Prophylactic Agent in Tibial Defects in Rats.
Koparal M; Ïrtegün S; Alan H; Deveci E; Gülsün B; Seker U
Anal Quant Cytopathol Histpathol; 2016 Apr; 38(2):111-6. PubMed ID: 27386632
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice.
Loiselle AE; Lloyd SA; Paul EM; Lewis GS; Donahue HJ
PLoS One; 2013; 8(11):e81399. PubMed ID: 24260576
[TBL] [Abstract][Full Text] [Related]
7. The effects of mechanically loaded osteocytes and inflammation on bone remodeling in a bisphosphonate-induced environment.
George EL; Truesdell SL; Magyar AL; Saunders MM
Bone; 2019 Oct; 127():460-473. PubMed ID: 31301402
[TBL] [Abstract][Full Text] [Related]
8. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.
Bellido T; Plotkin LI
Bone; 2011 Jul; 49(1):50-5. PubMed ID: 20727997
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of DMP1 and sclerostin in the epiphyseal trabecule and diaphyseal cortical bone of osteoprotegerin deficient mice.
Masuki H; Li M; Hasegawa T; Suzuki R; Ying G; Zhusheng L; Oda K; Yamamoto T; Kawanami M; Amizuka N
Biomed Res; 2010 Oct; 31(5):307-18. PubMed ID: 21079361
[TBL] [Abstract][Full Text] [Related]
10. Effect of zoledronate on the responses of osteocytes to acute parathyroid hormone.
Kuroshima S; Elliott KW; Yamashita J
Calcif Tissue Int; 2013 Jun; 92(6):576-85. PubMed ID: 23503790
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid decreases bone formation without causing osteocyte death in mice.
Huja SS; Fernandez SA; Phillips C; Li Y
Arch Oral Biol; 2009 Sep; 54(9):851-6. PubMed ID: 19591974
[TBL] [Abstract][Full Text] [Related]
12. Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis.
Smith EJ; McEvoy A; Little DG; Baldock PA; Eisman JA; Gardiner EM
J Bone Miner Res; 2004 Oct; 19(10):1698-705. PubMed ID: 15355565
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast and osteocyte-specific loss of Connexin43 results in delayed bone formation and healing during murine fracture healing.
Loiselle AE; Paul EM; Lewis GS; Donahue HJ
J Orthop Res; 2013 Jan; 31(1):147-54. PubMed ID: 22718243
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of osteoblast function in vitro by aminobisphosphonates.
Orriss IR; Key ML; Colston KW; Arnett TR
J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
[TBL] [Abstract][Full Text] [Related]
15. FGF23 is mainly synthesized by osteocytes in the regularly distributed osteocytic lacunar canalicular system established after physiological bone remodeling.
Ubaidus S; Li M; Sultana S; de Freitas PH; Oda K; Maeda T; Takagi R; Amizuka N
J Electron Microsc (Tokyo); 2009 Dec; 58(6):381-92. PubMed ID: 19549991
[TBL] [Abstract][Full Text] [Related]
16. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.
Bivi N; Condon KW; Allen MR; Farlow N; Passeri G; Brun LR; Rhee Y; Bellido T; Plotkin LI
J Bone Miner Res; 2012 Feb; 27(2):374-89. PubMed ID: 22028311
[TBL] [Abstract][Full Text] [Related]
17. Histochemical evidence of zoledronate inhibiting c-src expression and interfering with CD44/OPN-mediated osteoclast adhesion in the tibiae of mice.
Liu H; Cui J; Sun J; Du J; Feng W; Sun B; Li J; Han X; Liu B; Yimin ; Oda K; Amizuka N; Li M
J Mol Histol; 2015 Jun; 46(3):313-23. PubMed ID: 25969354
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model.
Tsubouchi Y; Ikeda S; Kataoka M; Tsumura H
J Orthop Surg Res; 2018 Oct; 13(1):267. PubMed ID: 30359257
[TBL] [Abstract][Full Text] [Related]
19. [Study on the effects of zoledronic-acid-loaded collagen membrane on bone metabolism cells].
Meng YH; Peng Y; Liu D; Chen Y; Wang H; Liang X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Feb; 46(2):107-11. PubMed ID: 21426781
[TBL] [Abstract][Full Text] [Related]
20. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
